Author:
Kirikoshi Hiroyuki,Saito Satoru,Yoneda Masato,Fujita Koji,Mawatari Hironori,Uchiyama Takashi,Higurashi Takuma,Imajo Kento,Sakaguchi Takashi,Atsukawa Kazuhiro,Sawabe Aya,Kanesaki Akira,Takahashi Hirokazu,Abe Yasunobu,Inamori Masahiko,Kobayashi Noritoshi,Kubota Kensuke,Ueno Norio,Nakajima Atsushi
Abstract
Abstract
Background
Spontaneous rupture is rare complication of hepatocellular carcinoma (HCC) with high mortality rate in cirrhotic cases. The aim of this study was to determine the factors influencing prognosis in cases of spontaneously ruptured HCC and to investigate the outcomes of the treatments employed, especially transcatheter arterial embolization (TAE).
Methods
A retrospective multicenter study was conducted in 48 cirrhotic patients with spontaneous rupture of HCC. Conservative treatment was employed in 32 patients (ConT group) and TAE was performed in 16 patients (TAE group).
Results
The median survival time (MST) in the ConT group was only 13.1 days and the survival rate was extremely poor: 59.4% at 7 days, 37.5% at 14 days, and 6.3% at 30 days. On the other hand, the MST in the TAE group was 244.8 days and the survival rate was 87.5% at 1 month, 56.3% at 3 months, 23.4% at 12 months, and 15.6% at 24 months. According to the results of univariate analyses, factors associated with poor hepatic function and poor suitability for TAE was important determinants of short-term death (less than 3 weeks) among the patients (p < 0.05). On the other hand, among the patients in whom initial TAE was successfully performed (n = 15), a multivariate analysis showed that a maximum tumor size not exceeding 7 cm was the only independent factor determining long-term survival (p = 0.0130).
Conclusion
Despite the inherent limitations of this retrospective study, TAE appears to be a useful treatment strategy for cirrhotic patients with spontaneous HCC rupture, as it yielded a longer survival period compared with conservative treatment in patients with ruptured HCC. Among the patients with ruptured HCC in whom initial TAE was successfully performed, the maximum tumor size was an important factor influencing survival.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference26 articles.
1. Xavier Bosch F: Global epidemiology of hepatocellular carcinoma. Liver Cancer. Edited by: Okuda K, Tabor E. 1997, New York Churchill Livingstone, 13-28.
2. Wanebo HJ, Falkson G, Order SE: Cancer of the hepatobiliary system. Cancer Principles and Practice of Oncology. Edited by: Devita VT Jr, Hellman S, Rosenberg SA. 1989, Philadelphia Lippincott, 836-874. 3
3. Kobayashi M, Ikeda K, Hosaka T, et al: Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections. J Med Virol. 2006, 78: 459-465. 10.1002/jmv.20562.
4. Okuda K, Fujimoto I, Hanai A, Urano Y: Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987, 47: 4967-4972.
5. Health and Welfare Statistics Association: Health and welfare statistics. J Health Welfare Stat. 2000, 47: 421-
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献